K-757 and K-833 for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Mar 2023: Trial started, NCT05890950
  2. 6 Jun 2023: Trial registered, NCT05890950

The trials

NCT05890950: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

State
Completed
Phase
Phase 1
People
24 taking part
Started
13 Mar 2023
Primary completion
12 Jul 2023
Arms
K-757 and K-833 combination
Results
None posted
  1. 13 Mar 2023: Trial started
  2. 6 Jun 2023: Trial registered
  3. 12 Jul 2023: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.